Biotech Marketing Agency · New Haven, CT
Biotech Marketing Agency in New Haven
Empire325 is a biotech marketing agency serving New Haven, Greater New Haven, and clients across Connecticut. Investor relations, scientific communications, and growth marketing for biotech, pharma, medtech, and life sciences companies.
Book a 15-min strategy callWhy New Haven for biotech & life sciences: New Haven's Yale University anchors a dense biopharma cluster — Arvinas, Achillion (now J&J), Alexion (now AstraZeneca), and BioAtla all launched from Yale research. Medical devices, clinical-stage biotech, and Yale-affiliated hospital procurement reward academic citation chains, white papers, and IRB-credible content.
What biotech marketing agency actually means in New Haven
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof.
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
Capabilities
What Empire325 delivers for New Haven biotech & life sciences clients
01
Investor relations
IR site builds, quarterly earnings communications, IPO/SPAC roadshow support, fact sheets, pipeline trackers, investor-day materials.
02
Scientific communications
Pipeline narrative, MOA explainers, publication strategy support, conference presentations, KOL-facing content under MLR review.
03
KOL programs
Key Opinion Leader identification, advisory boards, scientific symposia, peer-to-peer education programs aligned with corporate compliance and Sunshine Act reporting.
04
Commercial readiness
Pre-launch market shaping, payer-facing content, HCP digital presence, patient-advocacy partnerships in the 12-24 months before approval.
05
Partnership / BD marketing
Pharma-partnership marketing for licensing, collaboration, and M&A. Positioning content for BD conversations at JPM Healthcare, BIO, AACR, ASH, ASCO.
06
Compliance-aware analytics
Marketing attribution respecting HIPAA where applicable, plus PII/PHI handling appropriate to HCP, patient, investor, and partner audiences.
FAQ — Biotech Marketing Agency in New Haven
Does Empire325 serve biotech & life sciences clients in New Haven?
Yes. Empire325 is a biotech marketing agency serving New Haven, Greater New Haven, and clients across Connecticut. Investor relations, scientific communications, and growth marketing for biotech, pharma, medtech, and life sciences companies. Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
What makes New Haven unique for biotech & life sciences marketing?
New Haven's Yale University anchors a dense biopharma cluster — Arvinas, Achillion (now J&J), Alexion (now AstraZeneca), and BioAtla all launched from Yale research. Medical devices, clinical-stage biotech, and Yale-affiliated hospital procurement reward academic citation chains, white papers, and IRB-credible content. Empire325's biotech marketing agency programs in New Haven are tuned for this specific market dynamic — not generic playbooks ported from elsewhere.
Is Empire325 located in New Haven?
Empire325 Marketing is headquartered in West Babylon, NY 11704 (Suffolk County, Long Island, NY metro). We serve New Haven and clients across all 50 US states with senior-led engagements delivered remotely. For New Haven clients we coordinate via video, on-site visits as scope requires, and async collaboration tooling.
How much does biotech & life sciences marketing cost in New Haven?
Biotech Marketing Agency engagements in New Haven typically range $15K-$80K monthly retainers depending on scope, geographic reach (New Haven-only vs. multi-market), and lead-volume targets. Empire325 provides written scoping after a 30-minute discovery call.
What does Empire325 biotech marketing agency look like in New Haven specifically?
Investor relations, scientific communications, and growth marketing for biotech, pharma, medtech, and life sciences companies. In New Haven, that translates to programs informed by Greater New Haven market dynamics — New Haven's Yale University anchors a dense biopharma cluster — Arvinas, Achillion (now J&J), Alexion (now AstraZeneca), and BioAtla all launched from Yale research. Empire325 calibrates the biotech & life sciences playbook to the specific buyer, regulatory, and competitive realities of New Haven.
Other markets we serve
Biotech Marketing Agency in other cities
Need biotech & life sciences marketing in New Haven?
15-minute strategy call. No deck. No pitch. Just specific recommendations based on your context.
Book a 15-min strategy call